Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease

NCT03414788 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was withdrawn due to not being able to recruit subjects.

Conditions

Inflammatory Bowel Disease

Interventions

BIOLOGICAL: PF 06687234
BIOLOGICAL: [124I]IB PF 06687234

Sponsor

Pfizer